I need a company that operates successfully out of Latin America
Latin America has a combined population of more than 500 million people, patient enrollment is 3–6 times greater per site than the US, and the discontinuation rate is half of that in the US on average. That’s why we have a strategic base of operations in Mexico and significant trial activity throughout the whole of Latin America. In a recent endocrinology trial, for example, just 10 sites in Mexico yielded a similar number of patients to 40 US sites.
Another advantage of Latin America is “seasonal reversal.” For example, when it’s winter in the US and Europe, we can carry out allergy studies in Latin America. Disease prevalence in Latin America is different from the US and Western Europe – the population is not aging in the same way. However, a major therapeutic area in Latin America is diabetes, with a significantly higher incidence of the disease than in other regions of the world. Time zones in Latin America also offer a favorable advantage for US studies.
Case study: Meeting expectations in Latin America
We recently delivered a pediatric lower respiratory trial for a large pharmaceutical company, which randomized almost 600 patients in 13 months. The sample split was 80% Latin America, and 20% US and Canada. During enrollment we found that the best enrolling sites were Mexico, Panama and Costa Rica.
Additionally, we found that Latin America yielded 5.5 times as many patients per site as the US.
For further information on countries in this region, including key contacts, please click here Mexico | Peru
